OS Therapies Incorporated
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-17.6M | $171.5K |
| FY2023 | — | $-24.0M | $39.0K |
| FY2024 | — | $-3.3M | $5.5M |
| FY2025 | — | $-6.1M | $269.8K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-17.6M | $171.5K |
| FY2023 | — | $-24.0M | $39.0K |
| FY2024 | — | $-3.3M | $5.5M |
| FY2025 | — | $-6.1M | $269.8K |